218 related articles for article (PubMed ID: 20730482)
1. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
[TBL] [Abstract][Full Text] [Related]
2. Exogenous hormone use and meningioma risk: what do we tell our patients?
Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
[TBL] [Abstract][Full Text] [Related]
3. Risk of brain tumors associated with exposure to exogenous female sex hormones.
Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
[TBL] [Abstract][Full Text] [Related]
4. Hormonal therapies and meningioma: is there a link?
Cea-Soriano L; Blenk T; Wallander MA; Rodríguez LA
Cancer Epidemiol; 2012 Apr; 36(2):198-205. PubMed ID: 21943794
[TBL] [Abstract][Full Text] [Related]
5. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
[TBL] [Abstract][Full Text] [Related]
6. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone replacement therapy and meningioma.
Prescrire Int; 2010 Jun; 19(107):120. PubMed ID: 20738039
[TBL] [Abstract][Full Text] [Related]
8. Sex steroid hormone exposures and risk for meningioma.
Jhawar BS; Fuchs CS; Colditz GA; Stampfer MJ
J Neurosurg; 2003 Nov; 99(5):848-53. PubMed ID: 14609164
[TBL] [Abstract][Full Text] [Related]
9. Body mass index, comorbidities, and hormonal factors in relation to meningioma in an ethnically diverse population: the Multiethnic Cohort.
Muskens IS; Wu AH; Porcel J; Cheng I; Le Marchand L; Wiemels JL; Setiawan VW
Neuro Oncol; 2019 Mar; 21(4):498-507. PubMed ID: 30615143
[TBL] [Abstract][Full Text] [Related]
10. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.
Schwartzbaum J; Jonsson F; Ahlbom A; Preston-Martin S; Malmer B; Lönn S; Söderberg K; Feychting M
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):643-50. PubMed ID: 15767344
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
12. Intracranial meningioma and ionizing radiation in medical and occupational settings.
Phillips LE; Frankenfeld CL; Drangsholt M; Koepsell TD; van Belle G; Longstreth WT
Neurology; 2005 Jan; 64(2):350-2. PubMed ID: 15668439
[TBL] [Abstract][Full Text] [Related]
13. Brain tumors and hormonal factors: review of the epidemiological literature.
Cowppli-Bony A; Bouvier G; Rué M; Loiseau H; Vital A; Lebailly P; Fabbro-Peray P; Baldi I
Cancer Causes Control; 2011 May; 22(5):697-714. PubMed ID: 21359526
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and Progesterone Therapy and Meningiomas.
Hage M; Plesa O; Lemaire I; Raffin Sanson ML
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
[TBL] [Abstract][Full Text] [Related]
16. Handedness and risk of brain tumors in adults.
Inskip PD; Tarone RE; Brenner AV; Fine HA; Black PM; Shapiro WR; Selker RG; Linet MS
Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):223-5. PubMed ID: 12646512
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
J Neurooncol; 2018 Jan; 136(2):327-333. PubMed ID: 29081037
[TBL] [Abstract][Full Text] [Related]
18. [The taking of sex hormone preparations and the risk of developing breast cancer].
Levshin VF
Vopr Onkol; 1992; 38(8):899-909. PubMed ID: 1300798
[No Abstract] [Full Text] [Related]
19. Avoidable cancers in the Nordic countries. Exogenous hormones.
Winther JF; Dreyer L; Tryggvadottir L
APMIS Suppl; 1997; 76():132-40. PubMed ID: 9462825
[TBL] [Abstract][Full Text] [Related]
20. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.
Claus EB; Calvocoressi L; Bondy ML; Wrensch M; Wiemels JL; Schildkraut JM
J Neurosurg; 2013 Mar; 118(3):649-56. PubMed ID: 23101448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
